These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2435347)

  • 1. Subthreshold desensitization of human basophils.
    Minagawa K; Okada T
    Josai Shika Daigaku Kiyo; 1986; 15(3):588-93. PubMed ID: 2435347
    [No Abstract]   [Full Text] [Related]  

  • 2. Some invariant properties of IgE-mediated basophil activation and desensitization.
    Goldstein B; Dembo M; Sobotka AK; Lichtenstein LM
    J Immunol; 1979 Oct; 123(4):1873-82. PubMed ID: 90103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degranulation of human basophils: quantitative analysis of histamine release and desensitization, due to a bivalent penicilloyl hapten.
    Dembo M; Goldstein B; Sobotka AK; Lichtenstein LM
    J Immunol; 1979 Oct; 123(4):1864-72. PubMed ID: 90102
    [No Abstract]   [Full Text] [Related]  

  • 4. A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils.
    Tam SW; Demissie S; Thomas D; Daëron M
    Allergy; 2004 Jul; 59(7):772-80. PubMed ID: 15180766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-specific desensitization of human basophils.
    Sobotka AK; Dembo M; Goldstein B; Lichtenstein LM
    J Immunol; 1979 Feb; 122(2):511-7. PubMed ID: 84025
    [No Abstract]   [Full Text] [Related]  

  • 6. [Specific desensitization in allergic asthma].
    May K
    Gruzlica; 1975 Oct; 43(10):937-42. PubMed ID: 52571
    [No Abstract]   [Full Text] [Related]  

  • 7. Histamine release due to bivalent penicilloyl haptens the relation of activation and desensitization of basophils to dynamic aspects of ligand binding to cell surface antibody.
    Dembo M; Goldstein B; Sobotka AK; Lichtenstein LM
    J Immunol; 1979 Feb; 122(2):518-28. PubMed ID: 84026
    [No Abstract]   [Full Text] [Related]  

  • 8. An antigen-activated DFP-inhibitable enzyme controls basophil desensitization.
    Kazimierczak W; Meier HL; MacGlashan DW; Lichtenstein LM
    J Immunol; 1984 Jan; 132(1):399-405. PubMed ID: 6197452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthreshold and suboptimal desensitization human basophils. I. Kinetics of decay of releasability.
    Mendoza GR; Minagawa K
    Int Arch Allergy Appl Immunol; 1982; 68(2):101-7. PubMed ID: 6176554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transition from specific to nonspecific desensitization in human basophils.
    MacGlashan DW; Lichtenstein LM
    J Immunol; 1981 Dec; 127(6):2410-4. PubMed ID: 6170702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Desensitization of basophils. Dynamics of desensitization].
    Minagawa K; Okada T
    Josai Shika Daigaku Kiyo; 1983; 12(2):231-8. PubMed ID: 6585248
    [No Abstract]   [Full Text] [Related]  

  • 12. Augmentation of antigen-stimulated histamine release from human basophils by serum-treated zymosan particles. I. Characteristics of enhancement.
    Thomas LL; Lichtenstein LM
    J Immunol; 1979 Oct; 123(4):1462-7. PubMed ID: 90082
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of antigen binding on human basophils. II. Continued expression of antigen-specific IgE during antigen-induced desensitization.
    MacGlashan D; Mogowski M; Lichtenstein LM
    J Immunol; 1983 May; 130(5):2337-42. PubMed ID: 6187851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for atopic disease.
    Lieberman P; Patterson R
    Adv Intern Med; 1974; 19():391-411. PubMed ID: 4131290
    [No Abstract]   [Full Text] [Related]  

  • 15. Naturally occurring human antiglobulins with specificity for E.
    Williams RC; Griffiths RW; Emmons JD; Field RC
    J Clin Invest; 1972 Apr; 51(4):955-63. PubMed ID: 4111367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative characteristics of histamine release from human basophils by covalently cross-linked IgE.
    Kagey-Sobotka A; Dembo M; Goldstein B; Metzger H; Lichtenstein LM
    J Immunol; 1981 Dec; 127(6):2285-91. PubMed ID: 6170694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The concept of basophil releasability.
    Lichtenstein LM; MacGlashan DW
    J Allergy Clin Immunol; 1986 Feb; 77(2):291-4. PubMed ID: 2418091
    [No Abstract]   [Full Text] [Related]  

  • 18. Basophil releasability in the newborn: factors limiting immunoglobulin E-mediated histamine release.
    Mendoza GR; Minagawa K; Orner FB; Stiehm ER
    Pediatrics; 1982 Feb; 69(2):188-92. PubMed ID: 6173838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypersensitivity of the leukocytes in children with bronchial asthma. 2. Fluctuation of histamine liberation reaction of leukocytes during desensitization].
    Tomita A
    Nihon Shonika Gakkai Zasshi; 1971 Nov; 75(11):1017-21. PubMed ID: 4112291
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between basophil chemotaxis and histamine releasability to immunological stimulation.
    Vollrath IB; Gibbs BF; Wolff HH; Amon UE
    Inflamm Res; 1997 Mar; 46 Suppl 1():S11-2. PubMed ID: 9098741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.